Trump says he will order that the USA will only pay the price that other nations do for some drugs

President Trump says The costs of some medication. It is an attempt to revive A program he tried and failed implement during his first term.

The order that Mr. Trump promises Health and human services To bind what Medicare pays for medication that are administered in a doctor's office at the lowest price of other countries.

“I will set up a most preferred national policy in which the United States pay the same price as the nation that pays the lowest price everywhere in the world,” the President recorded on Sunday on his social media website and promised to sign the order in the White House on Monday morning.

“Our country is finally treated fairly, and the health costs of the citizens are reduced by numbers that have never been thought of before,” added Trump.

The president teased a “very large announcement” in the Oval Office last week, and sources confirmed CBS News on Friday that it was the so -called “most preferred” plan to reduce medication prices for medication.

Robert F. Kennedy Jr. From Mr. Trump's health and human services also pointed out politics on Tuesday and pointed out higher prices in Europe for the blockbuster -diabetes -drug -Ozempic.

“At the moment the big obstacle is really a price,” said Kennedy in an interview with Newsmax. “And we negotiate with the pharmaceutical companies and see whether we can start at least some pilot programs or whether we can make the price low enough, we can provide it for everyone at state costs.”

“If we do it in such a way that Medicaid, Medicare paid for it and that private insurance companies had to pay for it, we would double the costs of health insurance for most employers in this country. And that would be really destructive,” said Kennedy.

The proposal would probably only affect certain drugs covered by Medicare and administered in an office – think of infusions that treat cancer and other injectable games. Mr. Trump boasted that the government's plan would save “trillion dollars”, but the real number is unclear.

Medicare offers health insurance for around 70 million older Americans. Complaints about the US medicinal products prices that are notoriously high, even compared to other large and wealthy countries, have long drawn the anger of the legislators of both parties, but a permanent solution has never released the congress.

According to the planned order, the Federal Government would combine what it pays for, for these medication at the price of a group of other economically advanced countries.

The proposal will probably be exposed to violent oppositions of the pharmaceutical industry.

It was a rule that Mr. Trump tried to adopt in his first term, but could never get through. In the last few weeks of his presidency, he signed a similar executive regulation, but a court regulation later blocked the rule of going into force, cited questions during the regulation and later refused to pursue it after the bidges.

The pharmaceutical industry argued that Mr. Trump's attempt by Mr. Trump would give foreign governments the “upper hand” to decide the value of medication in the USA. The industry has long argued that the enforcement of lower prices will impair profits and ultimately influence innovation and its efforts to develop new medication.

Court commands of the drug industry and others blocked the centers for Medicare and Medicaid services or CMS from the implementation of the proposal in Mr. Trump's first term, and explained that the government did not go through the right steps to create and implement the guidelines.

The bidges administration gave up the proposal in 2022 and responsible for court commands that blocked the model and concerns of the stakeholders, including the fears that some Medicare beneficiaries could cut off by drugs and regular providers.

Only medication for Medicare Part B – insurance for visits to the doctor's office – should be covered. The Medicare beneficiaries are responsible for capturing some of the costs for obtaining these medication during visits to the doctor. For traditional Medicare participants, there is no annual upper limit for what you pay.

A report by the Trump administration during the first term showed that the United States spends twice as much as in some other countries when covering these medication. Medicare part B The pharmaceutical expenditure exceeded 33 billion US dollars in 2021.

More frequent prescription drugs that are subject to a pharmacy are probably not covered by the new order.

Mr. Trump occurred into his first term in which pharmaceutical companies accused “of murder” and complained that other countries whose governments determined the drug prices that used Americans.

On Sunday, the President again aimed at the industry and wrote that the “drug/pharmaceutical companies would say for years that it was research and development costs and that all of these costs alone would be borne by the 'Suckers' of America.

With reference to the mighty lobby efforts by the drugstores, he said that campaign contributions can “do miracles, but not with me and not with the Republican party”.

“We'll do the right thing,” he wrote.

Alexander Tin and Jennifer Jacobs contributed to this report.